Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
There’s a way to accurately determine if Venturis Therapeutics is a zombie company: the Zombie Biotech Company Quiz (ZBCQ). This expert diagnostic tool—a multiple-choice questionnaire—was developed by a BIO sub-committee and formally adopted in 2012 as the industry standard. The ZBCQ has been validated and accurately measures whether a company genuinely meets the threshhold of being a zombie biotech company:
1. When is/was the most recent clinical trial run by the company?
a) There are currently ongoing clinical trials.
b) The most recent clinical trial ended within the last 6 months.
c) The most recent clinical trial ended within the last 12 months.
z) In 2007 – over 13 years ago.
2. How many new investors have issued public statements announcing their investment in the company, as is customary in the biotech industry?
a) One
b) Two
c) Three
z) Zero – but that’s because all our new investors are SECRET investors – shhhhh.
3. How many partnering deals has the company announced in the last five years?
a) One
b) Two
c) Three
z) None – partnering deals are for losers who lack cojones.
4. What is the highest educational degree earned by the company’s Chairman/President?
a) Ph.D.
b) M.D.
c) MBA
z) High school diploma – who needs other degrees when you have a Texas high school education (#1 in the world!)
5. How much money is the company’s Chairman/President accused by the U.S. government bankruptcy trustee of stealing from his last company, which he ran into bankruptcy?
a) Zero - he has never stolen from anyone or any company.
b) Zero – leaders of integrity are never even accused of stealing.
c) Zero – because successful businessmen make so much money they don’t need to steal.
z) $14 million.
6. What does this biotech company take victory laps for?
a) Announcing successful clinical trial results.
b) Raising over-subscribed funding to run all its clinical trials and operations.
c) Generating record profits.
z) Patents, lawsuits, patents, lawsuits, lawsuits, lawsuits, lawsuits – what else matters?
7. How many years need to have passed before the former CEO who left the company over 5 years ago is no longer blamed for every problem the company has?
a) Zero – Leaders that are genuine winners don’t blame, they just solve problems and move ahead.
b) 1 year – A strong effective leader should be able to implement positive change within a year.
c) 2 years – It’s reasonable to appreciate that it takes time to fix problems, but beyond two years any truly capable leader understands he/she owns the problems, not someone else.
z) IT’S ALL DAN MONTANO’S FAULT AND ALWAYS WILL BE!!!
I believe the ZBCQ definitively puts the matter to rest - by the industry's standards, Venturis Therapeutics is a zombie biotech company.
If you'd like to better understand the realities of Venturis Therapeutics, here is more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153252377
There is not one Wall Street analyst that values a development-stage biotech company primarily or even secondarily through the prism of patents. Not one.
Do Wall Street analysts value biotech companies that have FDA-approved products on the market and active revenue streams through a prism (but not the only one) of patents? Yes, they do. But a development-stage zombie biotech company that has zero revenues, zero approved drugs, zero ongoing clinical trials, and is insolvent? HELL NO!
That Venturis Therapeutics's supporters feel the need to grossly misrepresent how things work shows one of two things: (1) they're idiots; or (2) they think everyone else is stupid.
But let's not forget that ZOMBIE COMPANIES only talk about things that are irrelevant. What zombie companies don't do is talk about the only thing that matters for a development-stage biotech company: running clinical trials.
Here's more information explaining why Venturis Therapeutics is a zombie biotech company:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153252377
More zombie lying: There is ZERO BASIS to claim that a U.S. patent exists that is not listed in the U.S. government's patent and trademark database.
ZERO.
This is yet another example of the lies that emerge from Venturis Therapuetics.
As of 1/19/2020, I see that the U.S. PTO database lists only these patents: the patent manufacturing FGF-1 via the phage prodution method (not in use) to treat coronary artery disease, the spine patent, and the E.D. patents. That's it.
Venturis Therapeutics's supporters keep providing all the proof any (even uninformed) third party needs to understand that Venturis Therapeutics is a ZOMBIE COMPANY. Zzzzombie.....zzzzombie....zzzzombie....
Here's even more proof that Venturis Therapeutics is a zombie company:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153252377
Patents? I just checked the U.S. PTO database and I do not find 7 issued patents, just the three we know of, most recently the erectile dysfunction patent that CVBT has already publicly announced in 2019. According to the PTO database, there were no new patents issued in the last 2 months of 2019 as you claim, but perhaps I missed them.
Would you kindly please describe what each of 7 patents are, and then show us a link on the U.S. government's PTO database where we can all see them?
Thank you!
You heard it here first - a major deal is soon to be announced with the North Koreans! The rumor I'm hearing from my Venturis Therapeutis sources is that the North Korean Sovereign Wealth Fund is investing 100 million won into Venturis Therapeutics. WOW!!!!
(and check those foreign exchange calculators you can find online before you start celebrating)
hahahahahaha
Here's the message this is in response to:
heartdr Saturday, 01/18/20 05:01:05 PM
Re: None
Post # of 1399
2020 - BANNER YEAR for VENTURIS DEALS
I am looking forward to hearing about the deal that VT has done with a major institution overseas.
VENTURIS THERAPEUTICS = ZOMBIE BIOTECH COMPANY
It's apparent that Venturis Therapeutics does not like being called exactly what it is: A ZOMBIE BIOTECH COMPANY.
A zombie biotech company is one that pretends to be viable and moving forward in its clinical trials, but is doing neither. The business of a development-stage biotech company is running clinical trials. Venturis Therapeutics has not run a single clinical trial since 2007. And since Calvin Wallen's hostile takeover in 2014, Venturis Therapeutics has run ZERO CLINICAL TRIALS. What they instead do is keep updating clinicaltrials.gov to make it appear that trials are going to start 6-12 months out. That game stops working when you've been playing it for YEARS yet nothing has advanced. For all the talk from Calvin Wallen III & Venturis Therapeutics (formerly Cardiovascular Biotherapeutics), effectively they have done NOTHING, i.e. run any clinical trials. That's pathetic. What they do seem to advance are excuses and lies and blame others. News flash: Excuses and lies and blaming others are the terrain of zombies and losers. Real companies run trials.
How does one obtain FDA approval of a drug? Not by amassing patents (and most of Venturis Therapeutics patents are laughable). Not by amassing lawsuits. Not by amassing a growing list of executives who leave the company. Not by playing balance sheet tricks that fool no one. FDA approval is obtained by running clinical trials. Real biotech companies run clinical trials. Zombie biotech companies don't, but instead talk about patents, lawsuits, staff, bogus balance sheets, former leadership, etc.. VENTURIS THERAPEUTICS REFUSES TO EXPLAIN WHY THEY HAVE NEVER ONCE MET ANY OF THEIR SELF-DETERMINED TIMELINES ON STARTING CLINICAL TRIALS AT ANY TIME DURING THE CALVIN WALLEN ERA. It's not a matter of being pathetic or inept, it's just that that's all a zombie company can do.
If it acts like a zombie, walks like a zombie, fails to run any clinical trials like a zombie, and effectively is dead like a zombie but keeps making noise (and boy does this zombie make lots of noise), then guess what: IT'S A ZOMBIE.
[insert your favorite Zombie noises here] hahahaha
If you'd like to better understand details of the zombie life that Venturis Therapeutics will in my opinion never emerge from, take a look at this:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153252377
Venturis Therapeutics: New name, same old zombie company - Updated
Venturis Therapeutics may be the new name for Cardiovascular Biotherapeutics (CVBT), but it's still the same old zombie company that has not run a single clinical trial since 2007 (that's 13 years and counting). I believe there are many reasons why Venturis Therapeutics will be closing its doors for good in 2020.
Here's what I believe is the actual situation at Venturis Therapeutics:
1) Insolvent: Venturis Therapeutics is insolvent, except now Venturis Therapeutics is likely playing Enron-style accounting tricks to make it appear otherwise ("debt-free balance sheet" as some on this message board claim - ummm, right). At the 2018 shareholders meeting (which is just a year and a half ago), Venturis Therapeutics CFO Robert Schleizer stated that the company received a going concern qualification from its auditors. So what's changed since then? The massive debt seems to have just magically disappeared, that's what. (And no audited financial statement has ever been released by the company, which says it all.)
2) Illiquid: Venturis Therapeutics is unable to pay its debts as they become due, according to bankruptcy judge Gary Spraker in 2019 (when the company was called Cardiovascular Biotherapeutics). This is a statement of fact that's in the public record, you don't need to take my word for it.
3) Alleged crook in charge: The majority shareholder, Chairman, and President of Venturis Therapeutics, Calvin Wallen III, is an accused crook and facing a trial in 2020 brought by the U.S. Government bankruptcy trustee for fraud and allegedly stealing $14 million from his previous company, Tauren Exploration Inc. Mr. Wallen, who only holds a high school diploma but likes to give the impression he has a college degree from Texas A&M that he doesn't have, has successfully delayed his day of reckoning for nearly two years, but it seems unlikely he will make it three. And Mr. Wallen has a trail of bankrupt companies to his name. Does anyone remember Cubic Energy Inc.?
4) Leadership is a revolving door: In the last year or so the company has lost its President, its Chief Medical Officer, and its Chief Science Officer. And everyone else that remains pretty much appears to be part-timers who also hold other jobs and are not even based in Dallas TX. Can anyone say, window dressing?
If you'd like to better understand these issues, here is more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153252377
Can you tell us, johnnyblades2001 on exactly what day Dan Montano was driving the Uber which picked you up in Las Vegas as you indicated in message #1371, copied in below?
johnnyblades2001 Saturday, 01/18/20 07:05:38 AM
Re: None
Post # of 1372
I am in Las Vegas for a conference this week. I wanted to check out the old CVBT headquarters. When my Uber arrived none other than Dan Montano was driving. He looked very sad. He didn't drive as fast as when he tried to escape being served his court papers. And luckily he didn't endanger any children or drive through any parks. He didn't offer me a water bottle so I gave him 2 stars. Slightly higher than I would have rated him as former CEO.
Pump and dump scheme?
WARNING - I believe a pump and dump scheme involving Venturis Therapeutics stock is playing out. There is a lot of hype and nonsense going on at the present time in my opinion, and it smells bad. If someone is offering you the opportunity to purchase Venturis Therapeutics stock at some sort of discount to some future IPO price or any other such nonsense, be very careful. As of the last time I checked, there are no registration filings with the SEC, and there is no IPO anywhere in sight. Further, claims of some imminent IPO, or partnering deal, or buyout, or ______ (fill in the blank) have been made anonymously on this message board repeatedly in the last several years and nothing has ever happened even though there is a flurry of message activity from a number of "users" on this board (which I believe are at best no more than 1-2 people posting under many different online identities). I believe someone is pushing very favorable (and typically demonstrably false) "rumors" about Venturis Therapeutics for what are nefarious reasons.
I believe anyone interested in Venturis Therapeutics would be wise to look closely at the following information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153252377
Venturis Therapeutics: New name, same old zombie company
Venturis Therapeutics may be the new name for Cardiovascular Biotherapeutics (CVBT), but it's still the same old zombie company that has not run a single clinical trial since 2007 (that's 13 years and counting!).
Further, I believe there's a new intensified disinformation campaign underway by Venturis Therapeutics to try and bury this information I'm posting under a lot of "noise" and transparent "pump and dump" tactics that I believe is all coming from Venturis Therapeutics leadership, to obscure the actual situation and in my opiniion engage in some sort of "pump and dump" scheme on unsuspecting individuals. So here's what I believe is the actual situation at Venturis Therapeutics:
1) Insolvent, except now Venturis Therapeutics may be playing Enron-like accounting tricks to make it appear otherwise ("debt-free balance sheet" as some on this message board claim - right!).
2) Illiquid - Venturis Therapeutics is unable to pay its debts as they become due, according to Cardiovascular Biotherapeutics' Bankruptcy Judge Gary Spraker in 2019 (it was called Cardiovascular Biotherapeutics at that time).
3) Alleged crook in charge: The majority shareholder, Chairman, and President of Venturis Therapeutics, Calvin Wallen III, is an accused crook and facing a trial in 2020 brought by the U.S. Government bankruptcy trustee for fraud and allegedly stealing $14 million from his previous company, Tauren Exploration Inc. Mr. Wallen, who only holds a high school diploma but likes to give the impression he has a college degree from Texas A&M that he doesn't have, has successfully delayed his day of reckoning for nearly two years, but it seems unlikely he will make it three. And Mr. Wallen has a trail of bankrupt companies to his name. Does anyone remember Cubic Energy Inc.?
4) Leadership is a revolving door: In the last year or so the company has lost its President, its Chief Medical Officer, and its Chief Science Officer. And everyone else that remains pretty much appears to be part-timers who also hold other jobs and are not even based in Dallas TX. Can anyone say, window dressing?
If you'd like to better understand these issues, here is more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153252377
Venturis Therapeutics: New name, same old zombie company
Venturis Therapeutics may be the new name for Cardiovascular Biotherapeutics (CVBT), but it's still the same old zombie company that has not run a single clinical trial since 2007 (that's 13 years!):
1) Insolvent, except now Venturis Therapeutics may be playing Enron-like accounting tricks to make it appear otherwise ("debt-free balance sheet" as some on this message board claim - right!).
2) Illiquid - Unable to pay its debts as they become due, according to Cardiovascular Biotherapeutics' Bankruptcy Judge Gary Spraker in 2019
3) Alleged crook in charge: The majority shareholder, Chairman, and President of Venturis Therapeutics, Calvin Wallen III, is an accused crook and facing a trial in 2020 brought by the U.S. Government bankruptcy trustee for fraud and allegedly stealing $14 million from his previous company, Tauren Exploration Inc. Mr. Wallen, who only holds a high school diploma but likes to give the impression he has a college degree from Texas A&M that he doesn't have, has successfully delayed his day of reckoning for nearly two years, but it seems unlikely he will make it three. And Mr. Wallen has a trail of bankrupt companies to his name. Does anyone remember Cubic Energy Inc.?
4) Leadership is a revolving door : In the last year or so the company has lost its President, its Chief Medical Officer, and its Chief Science Officer. And everyone else that remains pretty much appears to be part-timers who also hold other jobs and are not even based in Dallas TX. Can anyone say, window dressing?
If you'd like to better understand these issues, here is more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153252377
An update on the liver failure patient we discussed in December who I had hoped Venturis Therapeutics drug could help.
I thought I'd share with you all the sad news about the person I was hoping Venturis Therapeutics drug could help. This is my cousin's wife who is suffering from liver failure, the result of decades of alcoholism. While she had quit drinking in 2019, it was too late. The damage was done.
I saw her at Christmas and she looked terrible--lost weight, sunken eyes, no muscle definition left in her body, really she looked like death warmed over. We spoke at length and it was all I could do to not break down in tears as I listened. She told me she has made peace with her situation and has re-engaged with God, asking for forgiveness for the life she lived. She also told me that more than anything else in life she is pained that she was never able to have children (I assume this was due in some part to her lifelong alcoholism). She had had three miscarriages. We had all joked over the years that she over-compensated with her cats (she had 4), but that turns out to be the truth.
I just learned yesterday that she has been put into hospice. She doesn't have much time left unfortunately. I believe her eventual passing will be both very sad and a great relief to my cousin. I don't know how he has dealt with her issues over the years as he has. Being married to an alcoholic has been an incredible burden for him, as it would be for anyone. There are no winners here.
Venturis Therapeutics, the new name for Cardiovascular Biotherapeutics (CVBT), is in my opinion another way of saying re-arranging the furniture on the Titanic after hitting the iceberg.
"My heart will go on and on..."
An Open Communication To Venturis Therapeutics Leadership (formerly Cardiovascular Biotherapeutics a.k.a CVBT):
Dear Venturis Therapeutics Leadership,
Even though many have reported that Venturis Therapeutics leadership (formerly Cardiovascular Biotherapeutics or CVBT) doesn't return phone calls from shareholders, and thus communication with you all is basically impossible, we do know you read this message board. So here's what I'd like to tell you. I'd like to suggest you re-think your losing PR strategy of publicly denying (on this message board and elsewhere) the factual and the obvious truths of Venturis Therapeutics' situation, which any third party can see for themselves if they put in the effort to investigate (or know how to use Google or any other functioning search engine). Your current PR strategy is self-defeating and stupid.
While I've had some truly big laughs reading the messages here that DENY, as just one example, that Bankruptcy Judge Gary Spraker stated in the Venturis Therapeutics involuntary bankruptcy case (formerly Cardiovascular Biotherapeutics) that CVBT/Venturis is unable to pay its debts as they become due (which is in the public record), I do wonder at what point CVBT/Venturis will decide to stop shooting itself in the foot by continuing to deny that the sun rises in the east, deny that there are 24 hours in the day, deny that there are 7 days in a week, etc. I've already posted the public link to Judge Spraker's statement and yet various "individuals" on this message board keep denying that Judge Spraker ever said what he said--which we all know he said. And you know this better than anyone. I'm not going to re-post confirmation of Judge Spraker's statement of the dire financial condition of Venturis Therapeutics / CVBT because I don't respond to trolls, and I'd actually much prefer that you keep publicly denying it and making yourselves look even more stupid and less credible, if such a thing is remotely possible. If anyone would like to find where Judge Spraker made this statement of fact, just review all the messages I've posted on this message board, and you'll find it in one of them.
But on the other hand, I am a CVBT/Venturis Therapeutics shareholder even if I've long since given up on the company (and written off my losses), so at least I should nominally tell you that you make fools of yourselves with this ridiculous PR strategy. It's free advice, and feel free to ignore it too.
I'm sorry Venturis Therapeutics will be shutting its doors for good sometime in 2020. It shouldn't have ended as it is about to end. I have a feeling that a lot of shareholders, if they had the ability to re-do the shareholder vote that allowed Calvin Wallen III to succeed in his hostile takeover of CVBT/Venturis Therapeutics, would want to re-do that vote.
Here is a link to factual truths about Venturis Therapeutics which Venturis Therapeutics/CVBT is expending a lot of public effort to deny, confuse, and obfuscate:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153252377
And you know what else we can all look forward to in 2020? The trial that is soon to take place by the U.S. Government Bankruptcy Trustee against Venturis Therapeutics Chairman and President Calvin Wallen III, for fraud and allegedly stealing $14 million from his previous company Tauren Exploration Inc. which he ran into bankruptcy. Mr. Wallen has successful delayed this trial for coming up on two years, but it's all but certain the trial will take place once and for all in 2020. As soon as we have the new trial date, it will be posted here for all Venturis Therapeutics shareholders to be aware of. What I have such a difficult time understanding is why Mr. Wallen has repeatedly sought to delay his own trial if he is eager to clear his good name, as many "posters" have claimed on this message board. (There are also "posters" here who claim the whole matter will be settled and thus no trial will take place. From what I know, I agree--if Mr. Wallen pleads guilty to all charges. Based on the information in the public filings made by the U.S. Government, the feds more than have the goods on Mr. Wallen - names, dates, account numbers, of the monies he allegedly stole from Tauren and transferred into his personal control one way or another.)
Here are the links to the court records in these related cases:
Tauren Exploration, Inc. Liquidating Trust vs. Calvin Wallen III:
https://www.pacermonitor.com/public/case/24021776/Tauren_Exploration,_Inc_Liquidating_Trust_v_Wallen,_III
Tauren Exploration, Inc. Liquidating Trust vs. Pandale Holdings, Inc. et. al:
https://www.pacermonitor.com/public/case/24021775/Tauren_Exploration,_Inc_Liquidating_Trust_v_Pandale_Holdings,_Inc_et_al
Tauren Exploration, Inc. Liquidating Trust v. Fossil Operating, Inc. et al:
https://www.pacermonitor.com/public/case/24021777/Tauren_Exploration,_Inc_Liquidating_Trust_v_Fossil_Operating_Inc_et_al
If you’d like to better understand the actual state of Venturis Therapeutics and all the problems it is facing, you may wish to review this information:
Here is a link to Part 1 of the series on the Venturis Therapeutics disinformation campaign, fraud, and bankruptcy:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150306865
Here is a link to Part 2 of the series on the Venturis Therapeutics disinformation campaign, fraud, and bankruptcy:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150622197
VENTURIS THERAPEUTICS (formerly Cardiovascular Biotherapeutics) TO SHUT DOWN IN 2020 - MY PREDICTION
Whether it's called Cardiovascular Biotherapeutics (CVBT) or now Venturis Therapeutics (the new name, although the same old zombie company that is insolvent and illiquid), I believe Venturis Therapeutics will close its doors for good in 2020, especially after what I believe are very adverse developments Venturis Therapeutics will suffer in Q1 2020.
ALSO, is it not a fact that when a broken insolvent biotech company changes its name to get away from its sordid realities and baggage, that's a dead giveaway it's not going to end well? I'm racking my brain to think of any similar zombie biotech companies that have changed their name to get away from a terrible past (and present) and succeeded. Investors these days are far too sophisticated to fall for that sort of maneuver, and search engines are not going to be Venturis Therapeutics' friend (or Calvin Wallen's either).
Why do I believe Venturis Therapeutics is on the brink of shutting its doors forever? There are too many reasons (and this is not an exhaustive list of them):
1) Venturis Therapeutics remains an insolvent company based on generally accepted accounting principles (GAAP). I believe Venturis Therapeutics is claiming to be financially healthy only by playing accounting tricks and preparing financial statements that do not conform to GAAP. In fact, Venturis Therapeutic's CFO Robert Schleizer said in the 2018 annual shareholders meeting that Venturis Therapeutics' 2017 audited statement was going to receive a qualified opinion as a going concern from Venturis Therapeutics' auditors. And what has changed since then? It all smells like Enron.
2) According to CVBT's bankruptcy judge Gary Spraker in 2019, CVBT a.k.a. Venturis Therapeutics does not have the ability to pay its debts as they become due. That's not my opinion, that's a statement of fact from the bankruptcy judge for Venturis Therapeutics. (And it's in the public record.) My theory is that the name change from CVBT to Venturis Therapeutics may be due to Venturis Therapeutics' desire to make it more difficult for prospective partners and investors to find all of the CVBT baggage. But like I said, I believe Google and other search engines are not going to be Venturis Therapeutics' friends.
3) Venturis Therapeutics leadership keeps alarmingly turning over - people don't stick around. If things are going so well, why have the President, the Chief Medical Officer, and the equivalent of the Chief Science Officer all left their positions in 2019? And why did CVBT/Venturis Therapeutics try to so clumsily cover up the departure of the Chief Medical Officer, Dr. Ori Ben-Yehuda in particular, who stayed only a few weeks before leaving? What did Dr. Ben-Yehuda learn in those few weeks that made him run for the door? (Probably the same things that are making everyone else run for the door too.) Search for the press release that Cardiovascular Biotherapeutics issued announcing Dr. Ori Ben-Yehuda's arrival at the company. His departure was in only a matter of weeks--not that it was announced--but it was noticed by astute shareholders who saw that his name was pulled down from the website.
4) Venturis Therapeutics is being pursued by creditors right and left as I understand it, and Venturis Therapeutics has only kept creditors at bay by playing the game of delay, delay, delay. At some point, that game no longer works and the jig is up. I believe that point is in 2020.
5) The Chairman and President of Venturis Therapeutics, Calvin Wallen III, is being pursued by the U.S. government for fraud and for allegedly stealing $14 million from his previous now-bankrupt company, Tauren Exploration Inc. Mr. Wallen has also played the delay, delay, delay game to keep pushing back the start date of his trial, but again, at some point that stops working and the trial will happen. I believe it will happen in 2020. A TX bankruptcy attorney I spoke with who is familiar with the outlines of the case said to me, "the government does not lose cases like this." If Mr. Wallen is innocent as his supporters claim, then why would he be wanting to push back the date in which his alleged good name is cleared? I believe the reason why is because with this conviction, the curtain comes down for good. The conviction will automatically set in motion a series of events that will first result in referral for criminal prosecution (which my sources tell me is a mandatory referral because of the size of the alleged theft), and additionally, it will likely result in a referral to the IRS to determine if Mr. Wallen paid taxes on the $14 million in stolen money. If he did not pay those taxes (because under the law, one must also pay taxes on illegal income), well, I don't predict Mr. Wallen is going to enjoy his retirement so much.
Here are the links to the court records in these related cases:
Tauren Exploration, Inc. Liquidating Trust vs. Calvin Wallen III:
https://www.pacermonitor.com/public/case/24021776/Tauren_Exploration,_Inc_Liquidating_Trust_v_Wallen,_III
Tauren Exploration, Inc. Liquidating Trust vs. Pandale Holdings, Inc. et. al:
https://www.pacermonitor.com/public/case/24021775/Tauren_Exploration,_Inc_Liquidating_Trust_v_Pandale_Holdings,_Inc_et_al
Tauren Exploration, Inc. Liquidating Trust v. Fossil Operating, Inc. et al:
https://www.pacermonitor.com/public/case/24021777/Tauren_Exploration,_Inc_Liquidating_Trust_v_Fossil_Operating_Inc_et_al
And here's more information about the current troubled state of Venturis Therapeutics (formerly Cardiovascular Biotherapeutics):
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151409373
Coming up soon: New developments in the U.S. government's upcoming fraud trial against Venturis Therapeutics CEO Calvin Wallen III. Stay tuned...
An Open Commmunication To Cardiovascular Biotherapeutics (CVBT) Leadership
Dear CVBT Leadership,
Even though many have reported that CVBT's leadership doesn't return phone calls from shareholders and thus communication with you all is basically impossible, we do know you read this message board, so here's what I'd like to tell you. I'd like to suggest you re-think your losing PR strategy of publicly denying (on this message board and elsewhere) the factual and the obvious truths of CVBT's situation, which any third party can see for themselves if they put in the effort to investigate. Your current PR strategy is self-defeating and stupid.
While I've had some truly big laughs reading the messages denying as just one example that Judge Gary Spraker stated in CVBT's involuntary bankruptcy case that CVBT is unable to pay its debts as they become due, which is in the public record, I do wonder at what point CVBT will decide to stop shooting itself in the foot by continue to deny that the sun rises in the east, deny that there are 24 hours in the day, deny that there are 7 days in a week, etc. I've already posted the public link to Judge Spraker's statement and yet various "individuals" on this message board keep denying that Judge Spraker ever said what he said--which we all know he said, including you. I'm not going to re-post the confirmation of Judge Spraker's statement of CVBT's dire situation because I don't respond to trolls, and I'd actually much prefer that you keep publicly denying it. If anyone would like to find this reference, just review all the messages I've posted, and you'll find it in one of them.
But on the other hand, I am a CVBT shareholder even if I've long since given up on the company (and written off my losses), so at least I should nominally tell you that you make fools of yourselves with this ridiculous PR strategy. It's free advice, and feel free to ignore it too.
I'm sorry CVBT will be shutting its doors for good sometime in 2020. It shouldn't have ended as it is about to end. I have a feeling that a lot of shareholders, if they had the ability to re-do the shareholder vote that allowed Calvin Wallen III to succeed in his hostile takeover of CVBT, would want to re-do that vote.
Here is a link to factual truths about CVBT which CVBT is expending a lot of public effort to deny, confuse, and obfuscate:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153221930
CARDIOVASCULAR BIOTHERAPEUTICS (CVBT) TO SHUT DOWN IN 2020 - MY PREDICTION
Whether it's called Cardiovascular Biotherpeutics (CVBT) or "Venturis Therapeutics" as was just reported on this message board, I believe CVBT (or Venturis) will close its doors for good in 2020, especially after what I believe are very adverse developments CVBT will suffer in Q1 2020 - none of them good.
ALSO, it it not a fact that when a company in the biotech industry changes its name to get away from sordid results and/or lots of baggage, that's a dead giveaway it's not going to end well? I'm racking my brain to think of companies that have changed their name to get away from a terrible past (and present), and successfully done so. Investors these days are far too sophisticated to fall for that sort of maneuver, and search engines are not going to be CVBT's friends (or Calvin Wallen's either).
Why do I believe CVBT is on the brink of shutting its doors forever? There are too many reasons (and this is not an exhaustive list of them):
1) CVBT remains an insolvent company based on generally accepted accounting principles (GAAP). I believe CVBT is claiming to be financially healthy only by playing accounting tricks and preparing financial statements that do not conform to GAAP. In fact, CEO's CFO Robert Schleizer said in the 2018 annual shareholders meeting that CVBT's 2017 audited statement was going to receive a qualified opinion as a going concern from CVBT's auditors. And what has changed since then? It all smells like Enron.
2) According to bankruptcy judge Gary Spraker in 2019, CVBT does not have the ability to pay its bills as they become due. That's not my opinion, that's a statement of fact from a bankruptcy judge. (And it's in the public record.)
3) CVBT's leadership keeps alarmingly turning over - people don't stick around. If things are going so well, why have the President, the Chief Medical Officer, and the equivalent of the Chief Science Officer all left the company in 2019? And why did CVBT try to so clumsily cover up the departure of the Chief Medical Officer, Dr. Ori Ben-Yehuda in particular, who stayed only a few weeks before leaving? What did Dr. Ben-Yehuda learn in those few weeks that made him run for the door? (Probably the same things that are making everyone else run for the door too.)
4) CVBT is being pursued by creditors right and left as I understand it, and CVBT has only kept creditors at bay by playing the game of delay, delay, delay. At some point, that game no longer works and the jig is up. I believe that point is in 2020.
5) CVBT's CEO, Calvin Wallen III, is being pursued by the U.S. government for fraud and for allegedly stealing $14 million from his previous now-bankrupt company, Tauren Exploration Inc. Mr. Wallen has also played the delay, delay, delay game to keep pushing back the start date of his trial, but again, at some point that stops working and the trial will happen. I believe it will happen in 2020. A TX bankruptcy attorney I spoke with who is familiar with the outlines of the case said to me, "the government does not lose cases like this." If Mr. Wallen is innocent as his supporters claim, then why would he be wanting to push back the date in which his alleged good name is cleared? I believe the reason why is because with this conviction, the curtain comes down for good. The conviction will automatically set in motion a series of events that will first result in referral for criminal prosecution (which my sources tell me is a mandatory referral because of the size of the alleged theft), and additionally, it will likely result in a referral to the IRS to determine if Mr. Wallen paid taxes on the $14 million in stolen money. If he did not pay those taxes (because under the law, one must also pay taxes on illegal income), well, I don't predict Mr. Wallen is going to enjoy his retirement so much.
Here are the links to the court records in these related cases:
Tauren Exploration, Inc. Liquidating Trust vs. Calvin Wallen III:
https://www.pacermonitor.com/public/case/24021776/Tauren_Exploration,_Inc_Liquidating_Trust_v_Wallen,_III
Tauren Exploration, Inc. Liquidating Trust vs. Pandale Holdings, Inc. et. al:
https://www.pacermonitor.com/public/case/24021775/Tauren_Exploration,_Inc_Liquidating_Trust_v_Pandale_Holdings,_Inc_et_al
Tauren Exploration, Inc. Liquidating Trust v. Fossil Operating, Inc. et al:
https://www.pacermonitor.com/public/case/24021777/Tauren_Exploration,_Inc_Liquidating_Trust_v_Fossil_Operating_Inc_et_al
And here's more information about the current troubled state of CVBT:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151409373
Coming up soon: New developments in the U.S. government's upcoming fraud trial against CVBT CEO Calvin Wallen III. Stay tuned...
Regarding CVBT's drug and liver failure, I am REALLY hoping that CVBT's drug could help someone who is dying and in liver failure. I did some searching online and found this interesting article which gives me hope:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377328/
Can anyone from CVBT weigh in here? I have a family member who is a lifelong alcoholic and is at present dying from liver failure. She has lost so much weight and looks like a shell of her former self. It's incredibly sad to see. We all try and put up a good face when we're around her, but when we talk privately amongst ourselves, everyone admits to being horrified by her appearance. She'll be with us for Christmas and I'm hoping I might be able to share some information with her husband, my cousin.
This article says that growth factors can aid in liver regeneration, so I'm not crazy thinking that CVBT's drug could save the day here. In spite of her alcoholism, in spite of all that she has put the family through, we don't want her to die.
But the truth is, the end is very, very near for her. Maybe CVBT's drug is our only hope short of a miracle from God. Her doctor told her husband there's nothing further her medical team can do for her. Thoughts and prayers please.
Exhibit A: Why you need to BEWARE CVBT stock if someone is trying to sell it to you, in my opinion
For those of us who believe that some form of pump & dump scheme in CVBT stock is playing out (BEWARE!), it’s helpful to take a look closely at the claims being anonymously made here to entice unsuspecting investors to purchase CVBT stock (which is de-listed and can no longer trade publicly) in a private stock sale. A recent posting here deserves comment because it is Exhibit A for what I'm referring to. I’m going to copy in the nine (9) claims posted by a CVBT advocate, and my comments follow.
“CVBT has made more progress in the past year than any other year in recent memory.
New Patents have been issued
Balance Sheet cleaned up
Virtually debt free
Active Due Diligence ongoing from potential investors
New research partnerships formed
Relationships with investment banks
Judgments against adversaries likely to result in Millions of $ for CVBT
Legal actions soon to be resolved.”
OK, one at a time.
1. CVBT has made more progress in the past year than any other year in recent memory: Very little of this alleged progress is verifiable and so therefore I believe it has to be completely discounted until we see the proof, given CVBT’s track record of false promises. For example, some point to the clincaltrials.gov U.S. government website to say that CVBT’s clinical trials are close to resuming. That’s true, they have been close to resuming—for the last 3 years, continually. All that happens on clinicaltrials.gov is that CVBT keeps changing the dates in which trials are allegedly starting. CVBT’s clinical triaIs are like the horizon—they seem close, but you can never reach it. Clinicaltrials.gov is a self-reported database, so companies can put any information they want to post up there—and there’s no guarantee that it’s valid. In the case of CVBT, it has NEVER been valid in the last 3 years. I believe it’s just CVBT’s attempt to create an impression of things happening which aren’t. Smoke and mirrors. In my opinion this is just one example of how CVBT's leadership has abused the public's trust, and therefore we can not trust what CVBT says.
2. New Patents have been issued: Um, one new patent has been issued. That’s singular,not plural. And according to the expert I reached out to, this new patent has little actual real-world value, because erectile dysfunction is not a problem of perfusion but of blood pressure. But there’s no need to get into a debate on this subject. Let’s agree that CVBT has achieved a new patent. Anyone doing due diligence will quickly understand its true worth.
3. Balance Sheet cleaned up: Likely a 100% falsehood, because CVBT is almost certainly insolvent based on generally accepted accounting principles (GAAP). The burden of proof is on CVBT here. Show us the audited financial statements (which CVBT refuses to do) and then we’ll know for sure if the balance sheet really has been cleaned up. But there’s no reason to believe this claim is true. Why? CVBT’s CFO Robert Schleizer said at the 2018 shareholders meeting that the 2017 financial statement was going to be qualified by the auditors with a going concern disclaimer. So either CVBT has audited financial statements it won’t release because they do not have a clean auditor’s letter, or more likely, CVBT does not have current audited financial statements because they can’t get any auditor to sign off on their likely Enron-like accounting tricks showing a clean balance sheet. At the 2018 shareholders meeting Mr. Schleizer referred to CVBT’s $35 million in “legacy debt.” According to GAAP, there is no such term as “legacy debt.” The correct term is: debt. And unless debt has been repaid or settled, it exists and does not just go away when there's been a change in leadership or expire. Claims on this message board by CVBT supporters indicate that CVBT’s position is that statute of limitations has run on the “legacy debt.” Well to repeat, according to GAAP, there is no such thing as legacy debt, nor is there a statute of limitations on debt, period. Beware of the possibilty of Enron-like accounting tricks being played here. The red flags could not be waving more in my opinion.
4. Virtually-debt free: See paragraph above. This claim is nonsense. Show us the audited unqualified financial statements, and then we’ll have our answer. Further, CVBT's bankruptcy judge Gary Spraker said in 2019 that CVBT is unable to pay its debts as they become due. That statement from Judge Spraker is completely inconsistent with the claim that CVBT is virtually debt-free--because if the claim is true yet CVBT still can't pay their bills as they become due as Judge Spraker indicated, CVBT is in even worse shape than any of us might think. The claim in this pargraph is with 99.99999% certainty an outright lie.
5. Active Due Diligence ongoing from potential investors: This could be true, but what I’m absolutely sure of is that when potential investors discover in their due diligence that CVBT’s majority shareholder and CEO, Calvin Wallen III, is facing a trial in 2020 brought by the U.S. government for fraud and for allegedly stealing $14 million from his previous now-bankrupt company, Tauren Exploration, where he is also alleged to have falsified documents that were submitted to the bankruptcy court, these potential investors excuse themselves for a Starbucks break and never return.
6. New research partnerships formed: Could be true. And in my opinion this is 100% irrelevant for anyone looking to invest.
7. Relationships with investment banks: Almost certainly false unless the investment banks are from North Korean or Nigeria. I believe no credible investment bank would touch CVBT because CVBT’s CEO is facing a trial in 2020 brought by the U.S. government for fraud and for allegedly stealing $14 million from his previous now-bankrupt company, Tauren Exploration, where he is also alleged to have falsified documents. This is with 99.9999% certainty a complete lie.
8. Judgments against adversaries likely to result in Millions of $ for CVBT: It could be true, but I doubt it because the credibility of reports on this message board on lawsuit progress have proven to be unreliable at best and false at worse. I have no ability to address the substance of this claim other than to say time will tell. But the bigger issue is this: If lawsuits are the pathway for a company’s success, something is fundamentally off kilter. That CVBT supporters talk incessantly about lawsuits strongly suggests they don’t have their eye on the ball that matters.
9. Legal actions soon to be resolved: Ditto the above response.
The bottom line: The red flags are waving in my opinion. BEWARE.
For more information, read this:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=152887532
Liver failure: Does anyone know if CVBT's drug could be used to treat end-stage liver disease? Has CVBT done any research in this area?
I know someone who is in liver failure and is dying as a result of lifelong alcoholism. She doesn't have much time left. Could CVBT's drug save this woman? Or is she just going to die soon as we all expect? It's a horrible, horrible way to go. Just thinking about this poor women's fate makes me feel awful. I'm wishing, hoping, that CVBT's drug could be an option to save her life. She's unable to quit drinking but even if she did, her liver is pretty well fried at this point. She's not a candidate for a liver transplant. She has very little time left.
BEWARE - SOMETHING IS REALLY WRONG HERE
CVBT is a de-listed stock. It has not traded publicly in many years, and as of yesterday there are no SEC filings for it to be re-listed. Anyone who is being approached by someone to buy CVBT stock in a private transaction needs to be VERY CAUTIOUS. I believe a pump and dump scheme is being played out.
CVBT is an insolvent company that is on the verge of going out of business, and I personally believe CVBT will shut its doors for good in 2020. I'm a shareholder for well over a decade and I will lose when the doors close, but I've already written off my loss. I personally believe the leadership of CVBT are a bunch of con men. But you don't need to take my word for it. If you believe the U.S. government, the U.S. government is suing Calvin Wallen, CVBT's CEO, for fraud and allegedly stealing $14 million from his previous now-bankrupt company, Tauren Exploration Inc. I'll provide links below so anyone can learn more about these things.
BEWARE.
Here are the links to the court records in these related cases:
Tauren Exploration, Inc. Liquidating Trust vs. Calvin Wallen III:
https://www.pacermonitor.com/public/case/24021776/Tauren_Exploration,_Inc_Liquidating_Trust_v_Wallen,_III
Tauren Exploration, Inc. Liquidating Trust vs. Pandale Holdings, Inc. et. al:
https://www.pacermonitor.com/public/case/24021775/Tauren_Exploration,_Inc_Liquidating_Trust_v_Pandale_Holdings,_Inc_et_al
Tauren Exploration, Inc. Liquidating Trust v. Fossil Operating, Inc. et al:
https://www.pacermonitor.com/public/case/24021777/Tauren_Exploration,_Inc_Liquidating_Trust_v_Fossil_Operating_Inc_et_al
Here are some links that better explain the situation:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=152799896
Big pharma, medium pharma, and little pharma will not touch anything where there is even the slightest the whiff of fraud. CVBT unfortunately has the STENCH of fraud.
No reputable investment bank whill touch a company where there is even the slightest whiff of fraud. Not Goldman Sachs, not Morgan Stanley, not anyone even slightly credible.
The CEO of the Cardiovascular Biotherapeutics, Calvin Wallen III, is accused by the U.S. government of falsifying documents that were submitted to a bankruptcy court. That, my friend, is the very definition of fraud. Mr. Wallen faces an upcoming trial for fraud and for allegedly stealing $14 million from his former, now-bankrupt company, Tauren Exploration Inc.
Here are the links to the court records in these related cases:
Tauren Exploration, Inc. Liquidating Trust vs. Calvin Wallen III:
https://www.pacermonitor.com/public/case/24021776/Tauren_Exploration,_Inc_Liquidating_Trust_v_Wallen,_III
Tauren Exploration, Inc. Liquidating Trust vs. Pandale Holdings, Inc. et. al:
https://www.pacermonitor.com/public/case/24021775/Tauren_Exploration,_Inc_Liquidating_Trust_v_Pandale_Holdings,_Inc_et_al
Tauren Exploration, Inc. Liquidating Trust v. Fossil Operating, Inc. et al:
https://www.pacermonitor.com/public/case/24021777/Tauren_Exploration,_Inc_Liquidating_Trust_v_Fossil_Operating_Inc_et_al
And here's more information about the current troubled state of CVBT:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151409373
CARDIOVASCULAR BIOTHERAPEUTICS (CVBT) TO SHUT DOWN IN 2020 - MY PREDICTION
I believe CVBT will close its doors for good sometime in 2020, especially after what I believe are very adverse developments CVBT will suffer in Q1 2020 - none of them good.
Why do I believe this? There are too many reasons (and this is not an exhaustive list of them):
1) CVBT remains an insolvent company based on generally accepted accounting principles (GAAP). I believe CVBT is claiming to be financially healthy only by playing accounting tricks and preparing financial statements that do not conform to GAAP. In fact, CEO's CFO Robert Schleizer said in the 2018 annual shareholders meeting that CVBT's 2017 audited statement was going to receive a qualified opinion as a going concern from CVBT's auditors. And what has changed since then? It all smells like Enron.
2) According to bankruptcy judge Gary Spraker in 2019, CVBT does not have the ability to pay its bills as they become due. That's not my opinion, that's a statement of fact from a bankruptcy judge. (And it's in the public record.)
3) CVBT's leadership keeps alarmingly turning over - people don't stick around. If things are going so well, why have the President, the Chief Medical Officer, and the equivalent of the Chief Science Officer all left the company in 2019? And why did CVBT try to so clumsily cover up the departure of the Chief Medical Officer, Dr. Ori Ben-Yehuda in particular, who stayed only a few weeks before leaving? What did Dr. Ben-Yehuda learn in those few weeks that made him run for the door? (Probably the same things that are making everyone else run for the door too.)
4) CVBT is being pursued by creditors right and left as I understand it, and CVBT has only kept creditors at bay by playing the game of delay, delay, delay. At some point, that game no longer works and the jig is up. I believe that point is in 2020.
5) CVBT's CEO, Calvin Wallen III, is being pursued by the U.S. government for fraud and for allegedly stealing $14 million from his previous now-bankrupt company, Tauren Exploration Inc. Mr. Wallen has also played the delay, delay, delay game to keep pushing back the start date of his trial, but again, at some point that stops working and the trial will happen. I believe it will happen in 2020. A TX bankruptcy attorney I spoke with who is familiar with the outlines of the case said to me, "the government does not lose cases like this." If Mr. Wallen is innocent as his supporters claim, then why would he be wanting to push back the date in which his alleged good name is cleared? I believe the reason why is because with this conviction, the curtain comes down for good. The conviction will automatically set in motion a series of events that will first result in referral for criminal prosecution (which my sources tell me is a mandatory referral because of the size of the alleged theft), and additionally, it will likely result in a referral to the IRS to determine if Mr. Wallen paid taxes on the $14 million in stolen money. If he did not pay those taxes (because under the law, one must also pay taxes on illegal income), well, I don't predict Mr. Wallen is going to enjoy his retirement so much.
Here are the links to the court records in these related cases:
Tauren Exploration, Inc. Liquidating Trust vs. Calvin Wallen III:
https://www.pacermonitor.com/public/case/24021776/Tauren_Exploration,_Inc_Liquidating_Trust_v_Wallen,_III
Tauren Exploration, Inc. Liquidating Trust vs. Pandale Holdings, Inc. et. al:
https://www.pacermonitor.com/public/case/24021775/Tauren_Exploration,_Inc_Liquidating_Trust_v_Pandale_Holdings,_Inc_et_al
Tauren Exploration, Inc. Liquidating Trust v. Fossil Operating, Inc. et al:
https://www.pacermonitor.com/public/case/24021777/Tauren_Exploration,_Inc_Liquidating_Trust_v_Fossil_Operating_Inc_et_al
And here's more information about the current troubled state of CVBT:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151409373
There is ZERO CHANCE Goldman Sachs is working with CVBT. GS would never touch a company where the CEO is facing a trial brought by the U.S. government for fraud and allegedly stealing $14 million from his previous now-bankrupt company, as CVBT's CEO Calvin Wallen III is. That anyone would suggest such an insane thing that bears no resemblance to reality shows that someone here is trying to manipulate unsuspecting others.
Here are the links to the court records in these related cases:
Tauren Exploration, Inc. Liquidating Trust vs. Calvin Wallen III:
https://www.pacermonitor.com/public/case/24021776/Tauren_Exploration,_Inc_Liquidating_Trust_v_Wallen,_III
Tauren Exploration, Inc. Liquidating Trust vs. Pandale Holdings, Inc. et. al:
https://www.pacermonitor.com/public/case/24021775/Tauren_Exploration,_Inc_Liquidating_Trust_v_Pandale_Holdings,_Inc_et_al
Tauren Exploration, Inc. Liquidating Trust v. Fossil Operating, Inc. et al:
https://www.pacermonitor.com/public/case/24021777/Tauren_Exploration,_Inc_Liquidating_Trust_v_Fossil_Operating_Inc_et_al
And here's more information about the current troubled state of CVBT:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151409373
Hahaha! I believe no one is interested in a company where the CEO is being pursued by the feds for fraud and allegedly stealing $14 million from his previous now-bankrupt company, where there's a revolving door of leadership, where the CEO is grossly unqualified (whose background is in the oil and gas industry and who only has a high school diploma), and where the overall stench of fraud hangs.
Whoever you're referring to could have 200 million LinkedIn contacts and the result will be the same in my opinion: NO ONE MEANINGFUL WILL GET NEAR CVBT. And I believe in 2020 CVBT will finally close its doors for good.
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=152799896
Here's what CVBT is unwilling to tell shareholders:
1) Where are the audited financial statements we've all been promised for YEARS? We've yet to see a single one. Until we see an audited financial statement with the auditor's opinion letter, any reasonable shareholder or investor MUST assume CVBT continues to remain an insolvent company. The burden of proof is on CVBT to show us otherwise. According to CVBT CFO Robert Schleizer at the 2018 annual meeting, the 2017 audited financial statement had a qualified opinion letter from the auditors with a going concern qualification, although we've never seen that financial statement nor anything since--nor anything for over a decade, in spite of Mr. Wallen's (broken) promises otherwise. We know that CVBT's bankruptcy judge Gary Spraker said in 2019 that CVBT is unable to pay its bills as they become due. So what is it that CVBT does not want its shareholders to see?
2) Why do CVBT's clinical trials continuously get pushed back 6 months or more at a time? Anyone who has been watching clinicaltrials.gov can see that the start date is always some number of months into the future...and always has been for at least the last several years, the date just keeps changing (and prior to 2017, the information had not been updated since 2008). It's like chasing the horizon in the sky. CVBT has yet to post any information in this regard on clinicaltrials.gov that has been ACCURATE. Any reasonable person would ask the question, is this information intentionally inaccurate to create some sort of false impression among shareholders and prospective investors? Or is CVBT simply that incompetent in running its own trials? Which is it--or is it both?
3) Why is CVBT unable to retain executives? They seem to come and go quickly. In the last 12 months, CVBT has lost its President, its Chief Medical Officer, and its Executive VP of R&D (which is in effect the Chief Science Officer). Why is everyone leaving?
4) What succession planning does CVBT have assuming its CEO Calvin Wallen III is found guilty in his trial brought by the U.S. government where Mr. Wallen is accused of fraud and stealing $14 million from his previous now-bankrupt company, Tauren Exploration? In spite of Mr. Wallen's successful efforts to delay his trial for nearly 2 years, it's difficult to see how it won't finally take place in 2020. So once that happens and assuming Mr. Wallen is found guilty (and the case the government lays out in its filings it beyond damning--they show dates, amounts, and the bank accounts where the allegedly stolen monies were illegally transferred), how does CVBT survive his conviction? (My guess is CVBT will shut down at that point if it hasn't already before then, as Mr. Wallen apparently has been the company's only funding source.)
It's awesome that someone from CVBT's leadership is posting on this message board anonymously (and sometimes when sober). But for goodness sake, could you start answering these BUSINESS QUESTIONS??
CARDIOVASCULAR BIOTHERAPEUTICS (CVBT) TO SHUT DOWN IN 2020 IN MY OPINION
I believe CVBT will close its doors for good sometime in 2020, especially after what I believe are very adverse developments CVBT will suffer in Q1 2020 - none of them good.
Why do I believe this? There are too many reasons (and this is not an exhaustive list of them):
1) CVBT remains an insolvent company according to generally accepted accounting principles (GAAP). I believe they are claiming to be financially healthy only by playing accounting tricks and preparing financial statements that do not conform to GAAP. In fact, CEO's CFO Robert Schleizer said in the 2018 annual shareholders meeting that CVBT's 2017 audited statement was going to receive a qualified opinion as a going concern from CVBT's auditors. And what has changed since then? It all smells like Enron.
2) According to bankruptcy judge George Spraker in 2019, CVBT does not have the ability to pay its bills as they become due. That's not my opinion, that's a statement of fact from a bankruptcy judge. (And it's in the public record.)
3) CVBT's leadership keeps alarmingly turning over - people don't stick around. If things are going so well, why have the President, the Chief Medical Officer, and the equivalent of the Chief Science Officer all left the company in 2019? And why did CVBT try to so clumsily cover up the departure of the Chief Medical Officer, Dr. Ori Ben-Yehuda in particular, who stayed only a few weeks before leaving? What did Dr. Ben-Yehuda learn in those few weeks that made him run for the door? (Probably the same things that are making everyone else run for the door too.)
4) CVBT is being pursued by creditors right and left as I understand it, and CVBT has only kept creditors at bay by playing the game of delay, delay, delay. At some point, that game no longer works and the jig is up. I believe that point is in 2020.
5) CVBT's CEO, Calvin Wallen III, is being pursued by the U.S. government for fraud and for allegedly stealing $14 million from his previous now-bankrupt company, Tauren Exploration Inc. Mr. Wallen has also played the delay, delay, delay game to keep pushing back the start date of his trial, but again, at some point that stops working and the trial will happen. I believe it will happen in 2020. A TX bankruptcy attorney I spoke with who is familiar with the outlines of the case said to me, "the government does not lose cases like this." If Mr. Wallen is innocent as his supporters claim, then why would he be wanting to push back the date in which his alleged good name is cleared? I believe the reason why is because with this conviction, the curtain comes down for good. The conviction will automatically set in motion a series of events that will first result in referral for criminal prosecution (which my sources tell me is a mandatory referral because of the size of the alleged theft), and additionally, it will likely result in a referral to the IRS to determine if Mr. Wallen paid taxes on the $14 million in stolen money. If he did not pay those taxes (because under the law, one must also pay taxes on illegal income), well, I don't predict Mr. Wallen is going to enjoy his retirement so much.
Here are the links to the court records in these related cases:
Tauren Exploration, Inc. Liquidating Trust vs. Calvin Wallen III:
https://www.pacermonitor.com/public/case/24021776/Tauren_Exploration,_Inc_Liquidating_Trust_v_Wallen,_III
Tauren Exploration, Inc. Liquidating Trust vs. Pandale Holdings, Inc. et. al:
https://www.pacermonitor.com/public/case/24021775/Tauren_Exploration,_Inc_Liquidating_Trust_v_Pandale_Holdings,_Inc_et_al
Tauren Exploration, Inc. Liquidating Trust v. Fossil Operating, Inc. et al:
https://www.pacermonitor.com/public/case/24021777/Tauren_Exploration,_Inc_Liquidating_Trust_v_Fossil_Operating_Inc_et_al
And here's more information about the current troubled state of CVBT:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151409373
So what happened in court yesterday? Tell us about the incredible alleged victory for CVBT.
I'm surprised there has been such quiet here. Or is there a reason for that?
Any update on the Asian/North Korean investment banking deal for Cardiovascular Biotherapeutics (CVBT) that participants on this board told us was imminent this past summer? Hmmm...we haven't heard a word about it in like 6 months, even though it was on the cusp of happening.
Can the CVBT shill chorus chime in?
Here's more discussion of the topic:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150743462
FILLING THE CVBT MANAGEMENT VACANCIES
CVBT currently has two (2) open positions on its management team:
1) President (formerly, Mickael Flaa)
2) Chief Science Officer (formerly, Dr. Laurence Meyerson)
In order to jumpstart the clinical trials that are allegedly starting in 2020 (formerly 2019, and formerly 2018...), these management slots really need to be filled. But given that according to bankruptcy judge Gary Spraker CVBT is unable to pay its bills as they come due, how can CVBT find and afford talent at the scale necessary for these positions?
I have the perfect solution: CALVIN A. WALLEN IV
Yes, the son of the Glorious Leader Calvin Wallen III, would be PERFECT to take on these positions, for the following reasons:
1) He is the son of the Glorious Leader, and therefore that immediately makes him more qualified than anyone else.
2) He actually has a college degree from Texas A&M. If his father the Glorious Leader Calvin Wallen III could have achieved so much with only a high school diploma, imagine what Junior has to be capable of doing.
3) Calvin Wallen IV could fill BOTH these positions simultaneously, thus saving CVBT a boatload of money it doesn't have.
4) His degree is in IT, which makes him fully qualified to be in biotech because they share technology in common. Heck, when Dr. Warren Sherman leaves the company before not too long, Calvin Wallen IV could also become the Chief Medical Officer too, taking on a trifecta of positions. And why not?
5) This will give Calvin Wallen IV plenty of time to groom Calvin Wallen V to eventually take over leadership of the company one day and then hopefully re-start the clinical trials at that time.
6) The only problem this leaves CVBT shareholders with is an appropriate name of endearment for Calvin Wallen IV, following in the steps of the Glorious Leader, Calvin Wallen III. How about, the Charming Leader? (He seems charming enough.)
For more information about these management openings, take a look at this:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=152187611
The CVBT shill chorus is alive and well!
It's good to see that the Cardiovascular Biotherapeutics shill chorus is alive and well. The shill chorus has been touting astonishing victory after astonishing victory from a team of the greatest biotechnology talents ever brought together (mostly part-timers older than age 65), working in complete harmony to the greatest level of achievements imaginable, and all because of the Glorious Leader himself, Calvin Wallen III. For sure, the Glorious Leader's infinite accomplishments, in spite of only having a high school diploma, vastly exceed the greatest of leaders in all of history. Or something like that.
Unfortunately however, the shill chorus skips over that CVBT is an insolvent company that bankruptcy judge George Spraker stated in 2019 is unable to pay its bills as they come due, that there's a revolving door of its top people coming and going (mostly going these days), and that the CEO--Glorious Leader Wallen--is awaiting a trial he has successfully delayed for nearly 2 years, brought by the U.S. government for allegedly stealing $14 million from the last company he was running prior to CVBT, which he ran all the way into bankruptcy.
Shareholders, complete and total victory is right around the corner and the Glorious Leader is leading the way!!
I think this posting about the Current Troubled State of CVBT really sums the current situation up well:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=152187611
Dear Shill Chorus: Someone needs to write a song that directly speaks to the people about the Glorious Leader's infinite greatness. We look forward to hearing the .mp3 of the song soon. May I suggest a title: "I was NOTHING until Glorious Leader Wallen gave me reason to exist!"
CVBT SELF-DISCREDITING
Message to CVBT leadership: If you want to preserve the virtually non-existent credibility the company has left, you would be best advised to not state complete and obvious falsehoods as facts (posts #1145 & #1146).
Of the many possible examples (to say nothing of the rest of the nonsense in post #1145), consider just one--the false statements made in the above messages that CVBT's CEO and Chairman Calvin Wallen III is a graduate of Texas A&M. Mr. Wallen admitted under oath in court that he DOES NOT have a diploma from Texas A&M. Texas A&M's registrar does not list Calvin A Wallen III as a graduate of the university (although his son Calvin Wallen IV is listed as one). Attending a college does not mean you graduated from it, and Mr. Wallen DID NOT graduate from Texas A&M. Calvin Wallen III only holds a high school diploma.
Why does CVBT lie about Mr. Wallen's background? It's really unwise and thoroughly self-defeating. One can reasonably conclude that when lies are routinely stated about easily-proven facts, then nothing can be believed. It is just self-discreding. It reveals desperation.
CVBT is the only company in the biotech industry I'm aware of that is led by a CEO who only holds a high school diploma.
Question: Has CVBT set a new record here?
Reflecting on my addendum message posted just a few moments ago, I'm wondering, is anyone else aware of any other biotech company other than Cardiovascular Biotherapeutics (CVBT) that is led by someone who only has a high school diploma? I'm referring of course to the Dear Leader, Calvin Wallen III, CVBT's Chairman and CEO.
Doesn't this fact suggest that college degrees, graduate degrees, and Ph.D.s are vastly overrated and really not needed to run a biotech company?
Mr. Wallen, can you share the secrets of your success with us?
Addendum: The current troubled state of CVBT, Revolving Door Management Edition
My apologies, I said that there has been 100% turnover in all of CVBT's key leadership positions in the last year in my just-posted message. That's not fully accurate. Calvin Wallen is still on the team as its Chairman and CEO.
What I SHOULD have said is, CVBT has had 100% turnover in all of its leadership with any actual biotech industry experience and professional training. It STILL however has its CEO, a man with no previous biotech industry experience, whose entire career has been in the oil and gas industry running companies into bankruptcy, and who only has a high school diploma.
I again apologize for being slightly imprecise here and any confusion that may have caused.
Here is the link to my previous message:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=152187611
And because I know some have a hard time finding the court cases brought by the U.S. government bankruptcy trustee against CVBT's CEO Calvin Wallen III, here are links to the ongoing cases where Mr. Wallen will go on trial in 2020 for fraud and allegedly stealing $14 million from his previous company which he ran into bankruptcy:
Tauren Exploration, Inc. Liquidating Trust vs. Calvin Wallen III:
https://www.pacermonitor.com/public/case/24021776/Tauren_Exploration,_Inc_Liquidating_Trust_v_Wallen,_III
Tauren Exploration, Inc. Liquidating Trust vs. Pandale Holdings, Inc. et. al:
https://www.pacermonitor.com/public/case/24021775/Tauren_Exploration,_Inc_Liquidating_Trust_v_Pandale_Holdings,_Inc_et_al
Tauren Exploration, Inc. Liquidating Trust v. Fossil Operating, Inc. et al:
https://www.pacermonitor.com/public/case/24021777/Tauren_Exploration,_Inc_Liquidating_Trust_v_Fossil_Operating_Inc_et_al
The current troubled state of CVBT: Revolving Door Management Edition
In the last 12 months, CVBT has had 100% turnover in all its key leadership positions: the departure of its long-time President, the very brief stay of its Chief Medical Officer (whose very short tenure CVBT foolishly tried to hide), and now the unexpected departure of (in effect) its Chief Science Officer. And there are rumors that there could be more departures in the works, possibly including at least one Board member who reportedly is in the process of departing.
It's remarkable news that the lead scientist of Cardiovascular Biotherapeutics and allegedly the savior of the company, Dr. Laurence R. Meyerson, CVBT's EVP for R&D, has quietly left. There was no announcement from CVBT, just his name removed from the listing of the management team. More tellingly, Dr. Meyerson has scrubbed any mention of CVBT from his LinkedIn profile, which previously took up a lot of space on his page. That's more than odd - it suggests to me that something has gone seriously wrong and this was not a friendly parting. Could Dr. Meyerson have found out something really bad, and decided to cut ties with CVBT to preserve his good name?
In the last 12 months, CVBT has seen the departures of Mickael Flaa as President, the very brief heralded arrival and then very quick departure of Dr. Ori Ben-Yehuda as Chief Medical Officer, and now the departure of Dr. Laurence Meyerson. I guess lots of people really prefer to be spending much more time with their families! Or something like that...
Of course this means nothing negative about CVBT. As the shill squad will tell us, because of the bold decisive selfless actions of the Dear Leader, unbelievable riches are around the corner for us long-suffering shareholders. "Meyerson? He barely did anything here."
In a future post, I will be updating everyone on the upcoming trial of CVBT's CEO, Calvin Wallen III, brought by the U.S. Government Bankruptcy Trustee, for fraud and allegedly stealing $14 million from his former company. Here are links to these related cases. I haven't had any time to update myself on the situation so there may be developments I'm unaware of:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150365915
And here's more information about the current troubled state of CVBT:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151409373
The current troubled state of Cardiovascular Biotherapeutics – Updated
With efforts by unknown parties to obscure the true situation at Cardiovascular Biotherapeutics (CVBT) by making anonymous, unattributed claims to all sorts of wonderful developments for which there is no independent validating evidence, there is benefit to reviewing facts on the ground that can’t be disputed which paint a very different picture:
Here is a summary of the key points, with detail provided below:
1. According to CVBT's bankruptcy judge, CVBT is unable to pay its debts as they become due.
2. CVBT is insolvent.
3. CVBT’s management team are almost all part-timers with other jobs/consulting work, who are almost all past retirement age, yet are in positions that should require full-time effort.
4. CVBT’s CEO Calvin Wallen III is being sued by the U.S. government bankruptcy trustee for fraud and alleged theft of $14 million from his previous company.
5. According to CVBT's leadership, none of CVBT’s clinical programs have advanced in the last year, based on leadership’s report at the 2019 annual meeting. However, this is simply a continuation of the status quo since 2007.
6. There is almost certainly a crisis of corporate governance at CVBT.
In greater detail:
1. CVBT is unable to pay its debts as they become due according to Judge Gary Spraker in 2019 in the recent CVBT involuntary bankruptcy case.
2. CVBT is insolvent. In spite of the fact that anonymous comments indicate CVBT has minimal debt and a strong balance sheet, CVBT refuses to issue an audited financial statement. Why not? I believe this is because CVBT’s mountain of debts have not been re-paid or discharged by settlement and thus are still valid liabilities of CVBT in accordance with GAAP (generally accepted accounting principles). Instead, Mr. Wallen and others have publicly stated at CVBT’s shareholder meetings that the “legacy debts” are all beyond the statute of limitations and thus not collectable. So this suggests that CVBT has simply removed them from the balance sheet. Poof, they're gone — magic! Maybe such questionable accounting treatment qualifies under GAWAP (generally accepted Wallen accounting principles), but it does not meet the standards of GAAP and thus independent auditors. Until we see an audited financial statement that provides an unqualified auditor's opinion and reflects the anonymous claims that CVBT has minimal to no debt, it is reasonable to conclude that CVBT still has a mountain of unpaid debts and remains an insolvent company.
3. CVBT’s management team are almost all part-timers with other jobs/consulting work who are almost all past retirement age, yet in positions that should require full-time effort. This almost certainly reflects CVBT’s inability to afford full-time talent in the prime of their careers as is the norm in the biotech industry. Additionally, almost no one on CVBT’s management team is located in Dallas.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148216646
4. CVBT’s CEO Calvin Wallen III is being sued by the U.S. government bankruptcy trustee for fraud and alleged theft of $14 million from his previous company, and his upcoming trial (which Mr. Wallen has successfully delayed for nearly 1.5 years now) is likely to take place in early 2020.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150365915
5. According to CVBT's leadership, none of CVBT’s clinical programs have advanced in the last year based on leadership’s report at the 2019 annual meeting. However, this is simply a continuation of the status quo since 2007. At the 2019 annual meeting, CVBT indicated that the timelines to manufacture the drug and re-start the heart, wound healing, and PAD trials are now exactly 1 year later than the corresponding timelines that were provided at the 2018 annual meeting. That means that in the last year, CVBT has blown 100% of the timelines it laid out in 2018 and has made no forward progress on these fronts since then. Calvin Wallen never acknowledged or explained any of the delays, he just acted as if there were none and all is going according to plan.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149029245
6. Reasonable observers can conclude there is a crisis of governance at CVBT, because the Board of Directors has taken no public actions to separate or protect CVBT from Mr. Wallen’s alleged illegal activities. It is difficult to imagine that any investors would seriously consider investing in CVBT when the CEO is accused by the U.S. government of having stolen $14 million from the previous company he ran (into bankruptcy), and has an upcoming trial that he has repeatedly delayed. There is no evidence that the Board has taken appropriately prudent actions insisting that Mr. Wallen step aside temporarily until the matter is resolved one way or another. As such, CVBT is likely in an ongoing crisis of corporate governance in addition to all its other problems.
If you’d like to better understand these and other relevant issues, you may wish to review this information:
Here is a link to Part 1 of the series on the CVBT disinformation campaign, fraud, and bankruptcy:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150306865
Here is a link to Part 2 of the series on the CVBT disinformation campaign, fraud, and bankruptcy:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150622197
The current troubled state of Cardiovascular Biotherapeutics (CVBT)
With efforts by unknown parties to obscure the true situation at CVBT by making anonymous, unattributed claims to all sorts of developments for which there is no independent validating evidence, there is benefit to reviewing facts on the ground that can’t be disputed which paint a very different picture:
1. CVBT is unable to pay its debts as they become due according to Judge Gary Spraker in early 2019 in the recent CVBT involuntary bankruptcy case.
2. CVBT is insolvent. In spite of the fact that anonymous comments indicate CVBT has minimal debt and a strong balance sheet, CVBT refuses to issue an audited financial statement. Why not? I believe this is because CVBT’s mountain of debts have not been re-paid or discharged by settlement and thus are still valid liabilities of CVBT in accordance with GAAP (generally accepted accounting principles). Instead, Mr. Wallen and others have publicly stated at CVBT’s shareholder meetings that the “legacy debts” are all beyond the statute of limitations and thus not collectable. So this suggests that CVBT has simply removed them from the balance sheet. Poof, they're gone — magic! Maybe such questionable accounting treatment qualifies under GAWAP (generally accepted Wallen accounting principles), but it does not meet the standards of GAAP and thus independent auditors. Until we see an audited financial statement that provides an unqualified auditor's opinion and reflects the anonymous claims that CVBT has minimal to no debt, it is reasonable to conclude that CVBT still has a mountain of unpaid debts and remains an insolvent company.
3. CVBT’s management team are almost all part-timers with other jobs/consulting work who are almost all past retirement age, yet in positions that should require full-time effort. This almost certainly reflects CVBT’s inability to afford full-time talent in the prime of their careers as is the norm in the biotech industry. Additionally, almost no one on CVBT’s management team is located in Dallas.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=148216646
4. CVBT’s CEO Calvin Wallen III is being sued by the U.S. government bankruptcy trustee for fraud and alleged theft of $14 million from his previous company, and his upcoming trial (which Mr. Wallen has successfully delayed for nearly 1.5 years now) is likely to take place in early 2020.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150365915
5. Reasonable observers can conclude there is a crisis of governance at CVBT, because the Board of Directors has taken no public actions to separate or protect CVBT from Mr. Wallen’s alleged illegal activities. It is difficult to imagine that any investors would seriously consider investing in CVBT when the CEO is accused by the U.S. government of having stolen $14 million from the previous company he ran (into bankruptcy), and has an upcoming trial that he has repeatedly delayed. There is no evidence that the Board has taken appropriately prudent actions insisting that Mr. Wallen step aside temporarily until the matter is resolved one way or another. As such, CVBT is likely in an ongoing crisis of corporate governance in addition to all its other problems.
If you’d like to better understand these and other relevant issues, you may wish to review this information:
Here is a link to Part 1 of the series on the CVBT disinformation campaign, fraud, and bankruptcy:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150306865
Here is a link to Part 2 of the series on the CVBT disinformation campaign, fraud, and bankruptcy:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150622197
The CVBT Disinformation Campaign Appears To Be Intensifying
It appears that the Cardiovascular Biotherapeutics (CVBT) disinformation campaign continues to intensify in spite of contrary facts on the ground.
Exhibit A: Message #1082. It is difficult to believe that any truly serious investors are considering putting large sums into an insolvent company like CVBT.
Why? The reasons are too many to list. For starters, CVBT is not able to pay its debts as they become due according to Judge Gary Spraker, the CVBT involuntary bankruptcy judge. That's hardly the sort of situation any informed investor would jump into.
Further, CVBT's CEO Calvin Wallen III is being sued by the U.S. government bankruptcy trustee for fraud, and his upcoming trial (which Mr. Wallen has successfully delayed for nearly 1.5 years now) is likely to take place in early 2020. The U.S. government alleges that Mr. Wallen stole $14 million from Tauren Exploration Inc., the company he was previously CEO of before CVBT, and which Mr. Wallen also ran into bankruptcy.
Fraud. Bankruptcy. $14 million in stolen money. Until these matters are cleared up, I do not believe ANY informed investors are going to put money into CVBT.
I am presently at work on a future posting in our continuing series "CVBT and disinformation, fraud, and bankruptcy." Once I finish collecting information, I will post this latest entry in the series.
Until then, here is some additional reading:
Here is a link to Part 2 of this series on the CVBT disinformation campaign, fraud, and bankruptcy:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150622197
Here is a link to Part 1 of this series/extended discussion.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150306865
And here’s the latest update on the upcoming fraud trial of CVBT’s CEO, Calvin Wallen III:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150365915
And here's how bad things have gotten:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150504898
And with all the "rumors" of the Asian investment banking deal that is pending, here is my humorous take on the subject. The big reveal: It's a North Korean investment bank taking CVBT public at $50/share, and CVBT's stock will soon be trading on the Pyongyang stock exchange:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150743462
North Korean investors are all over CVBT, didn't you hear the rumors? The rumors are that the famous North Korean investment bank Kim Jong-un Sachs has inked a deal with CVBT to take CVBT public at $50/share and the stock will be listed on the Pyongyang stock exchange. Word is that investors in Chongjin have taken a particularly strong interest in this IPO. My guess is that we'll get the announcement from CVBT this week.
North Korea and CVBT - clearly well matched for one another.
And to get more information about the disinformation campaign that appears to be going on in favor of CVBT, read this:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150622197
And here's the latest information about the upcoming fraud trial of CVBT's CEO, Calvin Wallen III:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150365915
The rumored Asian investment bank taking CVBT public:
Like others, I've heard the persistent rumors that CVBT is about to close a deal with an Asian investment bank to take CVBT public. Wow, from my sources I'm just learned who it is: the famous North Korean investment bank, Kim Jong-un Sachs. And the rumor is that the price will be $50/share!
If this rumor is true, I personally want to congratulate Calvin Wallen III (!). In spite of the fact that Mr. Wallen has a trail of bankrupt companies to his name that he's run into the ground, in spite of the fact that the U.S. government is suing him for fraud and for allegedly stealing $14 million from his previous company (that he also ran into bankruptcy) and the upcoming trial will take place likely in early 2020, in spite of the fact that Mr. Wallen is the only biotech industry CEO I'm aware of who only has a high school diploma and comes from the oil and gas industry, the rumors suggest he's about to pull off the deal of a lifetime with the North Koreans!!
While we're waiting for these rumors to be confirmed by announcements from CVBT which I hope will be coming in a matter of days, here are some facts on the ground (with my opinions every now and then clearly delineated) about CVBT that anyone may find nteresting:
Here is Part 1 of our series/extended discussion on what's really going on at CVBT:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150306865
Here is Part 2 of our series/extended discussion on what's really happening at CVBT: (and more is to follow)
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150622197
And here’s the latest update on the upcoming fraud trial of CVBT’s CEO, Calvin Wallen III:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150365915
And here's how bad things have gotten:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150504898